1. Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
- Author
-
Riccarda Antiochia
- Subjects
Paper ,Coronavirus disease 2019 (COVID-19) ,Point-of-Care Systems ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,viruses ,paper-based microfluidics ,lcsh:Biotechnology ,Clinical Biochemistry ,paper-based-biosensor ,COVID-19 ,POC diagnostics ,lateral flow immunoassay ,nucleic acid later flow assay ,Review ,Biosensing Techniques ,02 engineering and technology ,Disease ,Viral antigen ,Computational biology ,01 natural sciences ,Viral gene ,lcsh:TP248.13-248.65 ,Humans ,Medicine ,Antigens, Viral ,Point of care ,Immunoassay ,SARS-CoV-2 ,business.industry ,010401 analytical chemistry ,General Medicine ,Paper based ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,RNA, Viral ,CRISPR-Cas Systems ,0210 nano-technology ,business ,Antibody detection - Abstract
This review summarizes the state of the art of paper-based biosensors (PBBs) for coronavirus disease 2019 (COVID-19) detection. Three categories of PBB are currently being been used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, namely for viral gene, viral antigen and antibody detection. The characteristics, the analytical performance, the advantages and drawbacks of each type of biosensor are highlighted and compared with traditional methods. It is hoped that this review will be useful for scientists for the development of novel PBB platforms with enhanced performance for helping to contain the COVID-19 outbreak, by allowing early diagnosis at the point of care (POC).
- Published
- 2021